GILD vs LPLA · P/E 18, rev $7.80B vs P/E 25, rev $10.13B
Gilead Sciences Inc (GILD) versus LPL Financial Holdings Inc (LPLA) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
LPL Financial Holdings Inc (LPLA) is a capital markets company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported LPLA revenue for 2026-06-30 was $10.13B. Net income was $735.7M. LPLA currently screens at market cap $22.61B and trailing P/E 25.5.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. LPLA currently screens at market cap $22.61B and trailing P/E 25.5.
Not investment advice. Open the GILD and LPLA stock pages for the full models.
Not investment advice.